Challenges in Treating Penile Cancer

At the ESMO Congress 2024, Andrea Necchi, MD, of San Raffaele Hospital and Scientific Institute, and Karine Tawagi, MD, of University of Illinois, highlight some the challenges that currently exist in the treatment of penile cancer, including “suboptimal” therapy options in the neoadjuvant and adjuvant space and a need for better biomarkers.

Dr. Necchi also opines on the trials that have him excited about the future of treatment in this rare disease, such as HERCULES.